会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Cephalosporins
    • 头孢菌素
    • US4316898A
    • 1982-02-23
    • US151694
    • 1980-05-20
    • Bernd WetzelEberhard WaitunRoland MaierWolfgang RueterUwe LechnerHans Goeth
    • Bernd WetzelEberhard WaitunRoland MaierWolfgang RueterUwe LechnerHans Goeth
    • A61K31/545A61K31/546A61P31/04C07D239/46C07D501/20C07D501/36C07D501/57
    • C07D239/47Y02P20/55
    • Cephalosporins of the formula ##STR1## wherein A is phenyl, 4-hydroxyphenyl, cyclohexyl, cyclohexene-1-yl, cyclohexa-1,4-diene-1-yl, 2-thienyl, 3-thienyl, 2-furyl, 3-furyl or 3,4-disubstituted phenyl, where the substituents, which may be identical to or different from each other, are each chlorine, hydroxyl or methoxy;Y is hydrogen or methoxy;D is hydrogen, hydroxyl, acetoxy, aminocarbonyloxy, pyridinium, aminocarbonyl-pyridinium or the group S-Het, where Het is 1-methyl-tetrazol-5-yl, tetrazol-5-yl, 3-methyl-1,2,4-thiadiazol-5-yl, 1,2,4-thiadiazol-5-yl, 1,3,4-thiadiazol-5-yl, 2-methyl-1,3,4-thiadiazol-5-yl, 2-methylamino-1,3,4-thiadiazol-5-yl, 2-dimethylamino-1,3,4-thiadiazol-5-yl, 2-formylamino-1,3,4-thiadiazol-5-yl, 2-acetylamino-1,3,4-thiadiazol-5-yl, 2-methyl-1,3,4-oxadiazol-5-yl, 1,2,3-triazol-4-yl or 1,2,4-triazol-3-yl;R is hydrogen, methyl, cyclopropyl, hydroxyl, methoxy, ethoxy, mercapto, morpholino, thiomorpholino, thiomorpholino-S-oxide, thiomorpholino-S,S-dioxide, ##STR2## E is hydrogen or a protective group which is easily removable in vitro or in vivo;and nontoxic, pharmacologically acceptable salts thereof.
    • 其中A为苯基,4-羟基苯基,环己基,环己烯-1-基,环己-1,4-二烯-1-基,2-噻吩基,3-噻吩基,2-呋喃基,3-甲氧基苯基, 呋喃基或3,4-二取代的苯基,其中可以相同或不同的取代基各自为氯,羟基或甲氧基; Y是氢或甲氧基; D是氢,羟基,乙酰氧基,氨基羰基氧基,吡啶鎓,氨基羰基 - 吡啶鎓或S-Het基团,其中Het是1-甲基 - 四唑-5-基,四唑-5-基,3-甲基-1,2,4- 噻二唑-5-基,1,2,4-噻二唑-5-基,1,3,4-噻二唑-5-基,2-甲基-1,3,4-噻二唑-5-基,2-甲基氨基 -1,3,4-噻二唑-5-基,2-二甲基氨基-1,3,4-噻二唑-5-基,2-甲酰氨基-1,3,4-噻二唑-5-基,2-乙酰基氨基-1 ,3,4-噻二唑-5-基,2-甲基-1,3,4-恶二唑-5-基,1,2,3-三唑-4-基或1,2,4-三唑-3-基 ; R是氢,甲基,环丙基,羟基,甲氧基,乙氧基,巯基,吗啉代,硫代吗啉代,硫代吗啉代-S-氧化物,硫代吗啉代-S,S-二氧化物,E是氢或保护基, 体外或体内可去除; 和无毒的药学上可接受的盐。
    • 3. 发明授权
    • Cephalosporins
    • 头孢菌素
    • US4364944A
    • 1982-12-21
    • US323382
    • 1981-11-20
    • Bernd WetzelEberhard WoitunWolfgang ReuterRoland MaierUwe LechnerHanns Goeth
    • Bernd WetzelEberhard WoitunWolfgang ReuterRoland MaierUwe LechnerHanns Goeth
    • C07D501/06A61K20060101A61K31/545A61K31/546C07D20060101C07D501/00C07D501/20C07D501/22C07D501/24C07D501/34C07D501/36C07D501/46C07D501/56C07D501/57
    • C07D501/20Y02P20/55
    • Compounds of the formula ##STR1## wherein Y is hydrogen or methoxy;A is ##STR2## or, when Y is methoxy, also phenyl, 4-hydroxy-phenyl, 2-thienyl, 3-thienyl of 3,4-dihydroxy-phenyl;A' is hydrogen, --COCH.sub.2 Cl, --COCH.sub.2 Br, --COOCH.sub.2 CCL.sub.3, formyl or trityl;D is hydrogen, acetoxy, aminocarbonyloxy, pyridinium, 4-aminocarbonyl-pyridinium or -S-Het, where Het is 3-methyl-1,2,4-thiadiazol-5-yl, 1,2,4-thiadiazol-5-yl, 1,3,4-thiadiazol-5-yl, 2-methyl-1,3,4-thiadiazol-5-yl, 4H-5,6-dioxo-1,2,4-triazine-3-yl, 4-methyl-5,6-dioxo-1,2,4-triazin-3-yl, 1-vinyl-tetrazol-5-yl, 1-allyl-tetrazol-5-yl or ##STR3## n is 1, 2 or 3; R.sub.1 is hydroxyl, amino, dimethylamino, acetylamino, aminocarbonyl, aminocarbonylamino, aminosulfonyl, aminosulfonylamino, methylcarbonyl, methylsulfonylamino, cyano, hydroxysulfonylamino, methylsulfonyl, methylsulfinyl, a carboxylic acid group or a sulfonic acid group; or--(CH.sub.2).sub.n R.sub.1 is alkyl of 1 to 4 carbon atoms or 2,3-dihydroxy-propyl;R.sub.2 is unsubstituted or monosubstituted 3-pyridyl, 5-pyrimidinyl, 2-thienyl, 2-furyl-methyl, 2-thienyl-methyl, 2-imidazolyl-methyl, 2-thiazolyl-methyl, 3-pyridyl-methyl or 5-pyrimidinyl-methyl, where the substituent is chlorine, methyl, acetylamino, hydroxyl, methylsulfinyl, methylsulfonyl, aminocarbonyl or aminosulfonyl; andE is hydrogen or a carboxyl-protective group which is easily removable in vitro or in vivo;and, E is hydrogen, non-toxic, pharmacologically acceptable salts thereof formed with inorganic or organic bases; the compounds as well as their salts are useful as antibiotics.
    • 其中Y是氢或甲氧基的式“IMAGE”的化合物; A是,或者当Y是甲氧基时,3,4-二羟基 - 苯基的苯基,4-羟基 - 苯基,2-噻吩基,3-噻吩基; A'是氢,-COCH 2 Cl,-COCH 2 Br,-COOCH 2 CCl 3,甲酰基或三苯甲基; D是氢,乙酰氧基,氨基羰氧基,吡啶鎓,4-氨基羰基 - 吡啶鎓或-S-Het,其中Het是3-甲基-1,2,4-噻二唑-5-基,1,2,4-噻二唑-5-基, 1,3,4-噻二唑-5-基,2-甲基-1,3,4-噻二唑-5-基,4H-5,6-二氧代-1,2,4-三嗪-3-基, 4-甲基-5,6-二氧代-1,2,4-三嗪-3-基,1-乙烯基 - 四唑-5-基,1-烯丙基 - 四唑-5-基或n为1,2 或3; R1是羟基,氨基,二甲基氨基,乙酰基氨基,氨基羰基,氨基羰基氨基,氨基磺酰基,氨基磺酰基氨基,甲基羰基,甲基磺酰基氨基,氰基,羟基磺酰基氨基,甲基磺酰基,甲基亚磺酰基,羧酸基或磺酸基团。 或 - (CH 2)n R 1是1至4个碳原子的烷基或2,3-二羟基 - 丙基; R2是未取代的或单取代的3-吡啶基,5-嘧啶基,2-噻吩基,2-呋喃基 - 甲基,2-噻吩基 - 甲基,2-咪唑基 - 甲基,2-噻唑基 - 甲基,3-吡啶基 - 甲基或5-嘧啶基 甲基,其中取代基是氯,甲基,乙酰氨基,羟基,甲基亚磺酰基,甲基磺酰基,氨基羰基或氨基磺酰基; E是氢或羧基保护基,其在体外或体内容易除去; 和E是氢,与无机或有机碱形成的无毒的药理学上可接受的盐; 化合物及其盐可用作抗生素。
    • 7. 发明授权
    • Cephalosporins
    • 头孢菌素
    • US4388315A
    • 1983-06-14
    • US307117
    • 1981-09-30
    • Bernd WetzelEberhard WoitunRoland MaierWolfgang ReuterUwe LechnerHanns Goeth
    • Bernd WetzelEberhard WoitunRoland MaierWolfgang ReuterUwe LechnerHanns Goeth
    • A61K31/545A61K31/546A61P31/04C07D239/46C07D501/20C07D501/36C07D501/57
    • C07D239/47Y02P20/55
    • Cephalosporins of the formula ##STR1## wherein A is phenyl, 4-hydroxyphenyl, cyclohexyl, cyclohexene-1-yl, cyclohexa-1,4-diene-1-yl, 2-thienyl, 3-thienyl, 2-furyl, 3-furyl or 3,4-disubstituted phenyl, where the substituents, which may be identical to or different from each other, are each chlorine, hydroxyl or methoxy;Y is hydrogen or methoxy;D is hydrogen, hydroxyl, acetoxy, aminocarbonyloxy, pyridinium, aminocarbonyl-pyridinium or the group S-Het, where Het is 1-methyl-tetrazol-5-yl, tetrazol-5-yl, 3-methyl-1,2,4-thiadiazol-5-yl,1,2,4-thiadiazol-5-yl, 1,3,4-thiadiazol-5-yl, 2-methyl-1,3,4-thiadiazol-5-yl, 2-methylamino-1,3,4-thiadiazol-5-yl, 2-dimethylamino-1,3,4-thiadiazol-5-yl, 2-formylamino-1,3,4-thiadiazol-5-yl, 2-acetylamino-1,3,4-thiadiazol-5-yl, 2-methyl-1,3,4-oxadiazol-5-yl, 1,2,3-triazol-4-yl or 1,2,4-triazol-3-yl;R is hydrogen, methyl, cyclopropyl, hydroxyl, methoxy, ethoxy, mercapto, morpholino, thiomorpholino, thiomorpholino-S-oxide, thiomorpholino-S,S-dioxide, ##STR2## E is hydrogen or a protective group which is easily removable in vitro or in vivo;and non-toxic, pharmacologically acceptable salts thereof.
    • 其中A为苯基,4-羟基苯基,环己基,环己烯-1-基,环己-1,4-二烯-1-基,2-噻吩基,3-噻吩基,2-呋喃基,3-甲氧基苯基, 呋喃基或3,4-二取代的苯基,其中可以相同或不同的取代基各自为氯,羟基或甲氧基; Y是氢或甲氧基; D是氢,羟基,乙酰氧基,氨基羰基氧基,吡啶鎓,氨基羰基 - 吡啶鎓或S-Het基团,其中Het是1-甲基 - 四唑-5-基,四唑-5-基,3-甲基-1,2,4- 噻二唑-5-基,1,2,4-噻二唑-5-基,1,3,4-噻二唑-5-基,2-甲基-1,3,4-噻二唑-5-基,2-甲基氨基 -1,3,4-噻二唑-5-基,2-二甲基氨基-1,3,4-噻二唑-5-基,2-甲酰氨基-1,3,4-噻二唑-5-基,2-乙酰基氨基-1 ,3,4-噻二唑-5-基,2-甲基-1,3,4-恶二唑-5-基,1,2,3-三唑-4-基或1,2,4-三唑-3-基 ; R是氢,甲基,环丙基,羟基,甲氧基,乙氧基,巯基,吗啉代,硫代吗啉代,硫代吗啉代S-氧化物,硫代吗啉代-S,S-二氧化物,E是氢或保护基, 在体外或体内容易移除; 和无毒的药理学上可接受的盐。
    • 9. 发明授权
    • Cephalosporin derivatives
    • 头孢菌素衍生物
    • US4415566A
    • 1983-11-15
    • US191423
    • 1980-09-26
    • Bernd WetzelEberhard WoitunWolfgang ReuterRoland MaierUwe LechnerHanns Goeth
    • Bernd WetzelEberhard WoitunWolfgang ReuterRoland MaierUwe LechnerHanns Goeth
    • C07D499/66A61K31/43A61K31/545A61K31/546A61P31/04C07D239/36C07D499/00C07D499/64C07D499/68C07D499/70C07D501/20C07D501/22C07D501/34C07D501/36C07D501/46
    • C07D239/36C07D499/00Y02P20/55
    • Penicillins and cephalosporins of the formula ##STR1## wherein A is phenyl, 4-hydroxyphenyl, cyclohexyl, cyclohene-1-yl, cyclohexa-1,4-diene-1-yl, 2-thienyl, 3-thienyl, 2-furyl, 3-furyl or 3,4-disubstituted phenyl, where the substituents, which may be identical to or different from each other, are each chlorine, hydroxyl or methoxy;R.sub.1 is an unsubstituted or substituted 5- or 6-membered heterocycle comprising carbon atoms and 1 to 4, preferably 1 to 2, identical or different heteroatoms such as oxygen, sulfur or nitrogen;n is 0 or 1;X is ##STR2## D is hydrogen, hydroxyl, acetoxy, aminocarbonyloxy, pyridinium, aminocarbonyl-pyridinium or S-Het, where Het is 1-methyl-tetrazol-5-yl, tetrazol-5-yl, 3-methyl-1,2,4-thiadiazol-5-yl, 1,2,4-triadiazol-5-yl, 1,3,4-thiadiazol-5-yl, 2-methyl-1,3,4-thiadiazol-5-yl, 2-methylamino-1,3,4-thiadiazol-5-yl, 2-dimethylamino-1,3,4-thiadiazol-5-yl, 2-formylamino-1,2,4-thiadiazol-5-yl, 2-acetylamino-1,3,4-thiadiazol-5-yl, 2-methyl-1,3,4-oxadiazol-5-yl, 1,2,3-triazol-4-yl or 1,2,4-triazol-3-yl; andE is hydrogen or a protective group which is easily removable in nitro or in vivo, especially an ester-forming group which can be removed under mild conditions by hydrogenation or hydrolysis or other treatments, or an ester-forming group which can easily be split off in the living organism;and, when E is hydrogen, their non-toxic, pharmacologically acceptable salts thereof, such as their alkali metal or alkaline earth metal salts, especially the sodium, potassium, magnesium or calcium salts; their ammonium salts; or their organic amine salts, especially the triethylamine or dicyclohexylamine salts. The compounds are useful as antibiotics.
    • 其中A是苯基,4-羟基苯基,环己基,环烯-1-基,环己-1,4-二烯-1-基,2-噻吩基,3-噻吩基,2-呋喃基, 3-呋喃基或3,4-二取代的苯基,其中可以相同或不同的取代基各自为氯,羟基或甲氧基; R1是包含碳原子和1至4个,优选1至2个相同或不同的杂原子如氧,硫或氮的未取代或取代的5或6元杂环; n为0或1; X是H,羟基,乙酰氧基,氨基羰基氧基,吡啶鎓,氨基羰基 - 吡啶鎓或S-Het,其中Het是1-甲基 - 四唑-5-基,四唑-5-基,3-甲基-1- 2,4-噻二唑-5-基,1,2,4-三唑-5-基,1,3,4-噻二唑-5-基,2-甲基-1,3,4-噻二唑-5-基, 2-甲基氨基-1,3,4-噻二唑-5-基,2-二甲基氨基-1,3,4-噻二唑-5-基,2-甲酰氨基-1,2,4-噻二唑-5-基,2- 乙酰氨基-1,3,4-噻二唑-5-基,2-甲基-1,3,4-恶二唑-5-基,1,2,3-三唑-4-基或1,2,4-三唑-4-基, 吡啶-3-基; E是氢或在硝基或体内容易除去的保护基团,特别是可在温和条件下通过氢化或水解或其它处理方法除去的酯形成基团或易于分解的酯形成基团 在有机体中脱落; 并且当E是氢时,其无毒的药学上可接受的盐,例如它们的碱金属或碱土金属盐,特别是钠,钾,镁或钙盐; 其铵盐; 或它们的有机胺盐,特别是三乙胺或二环己基胺盐。 该化合物可用作抗生素。
    • 10. 发明授权
    • Cephalosporins
    • 头孢菌素
    • US4401667A
    • 1983-08-30
    • US323432
    • 1981-11-20
    • Bernd WetzelEberhard WoitunWolfgang ReuterRoland MaierUwe LechnerHanns Goeth
    • Bernd WetzelEberhard WoitunWolfgang ReuterRoland MaierUwe LechnerHanns Goeth
    • C07D501/06A61K20060101A61K31/545A61K31/546A61P31/04C07C20060101C07D20060101C07D501/00C07D501/24C07D501/36C07D501/46C07D501/54C07D501/56
    • C07D501/36Y02P20/55
    • Compounds of the formula ##STR1## wherein A is phenyl, 4-hydroxy-phenyl, 2-thienyl, 3-thienyl or 3,4-dihydroxy-phenyl;Het is 4H-5,6-dioxo-1,2,4-triazin-3-yl, 4-methyl-5,6-dioxo-1,2,4-triazin-3-yl, 1-vinyl-tetrazol-5-yl, 1-allyl-tetrazol-5-yl or ##STR2## where n is an integer from 1 to 3, inclusive,R.sub.1 is hydroxyl, amino, dimethylamino, acetylamino, aminocarbonyl, aminocarbonylamino, aminosulfonyl, aminosulfonylamino, methylcarbonyl, methylsulfonylamino, cyano, hydroxysulfonylamino, methylsulfonyl, methylsulfinyl, a carboxylic acid group or a sulfonic acid group, or --(CH.sub.2).sub.n --R.sub.1 may also be alkyl of 2 to 4 carbon atoms or 2,3-dihydroxy-propyl;R.sub.2 is an unsubstituted or monosubstituted heterocyclic radical selected from the group consisting of 3-pyridyl, 5-pyrimidinyl, 2-thienyl, 2-furylmethyl, 2-thienylmethyl, 2-imidazolylmethyl, 2-thiazolylmethyl, 3-pyridylmethyl or 5-pyrimidinylmethyl, where the substituent is chlorine, methyl, acetylamino, hydroxyl, methylsulfinyl, methylsulfonyl, aminocarbonyl or aminosulfonyl; andE is hydrogen or a protective group which is easily removable in vitro or in vivo;and, when E is hydrogen, non-toxic, pharmacologically acceptable salts thereof formed with inorganic or organic bases; the compounds as well as their salts are useful as antibiotics.
    • 其中A是苯基,4-羟基 - 苯基,2-噻吩基,3-噻吩基或3,4-二羟基 - 苯基的式 Het是4H-5,6-二氧代-1,2,4-三嗪-3-基,4-甲基-5,6-二氧代-1,2,4-三嗪-3-基,1-乙烯基 - 其中n为1〜3的整数,包括1和3的整数,R1为羟基,氨基,二甲基氨基,乙酰氨基,氨基羰基,氨基羰基氨基,氨基磺酰基,氨基磺酰基氨基,甲基羰基,甲基磺酰基氨基 ,氰基,羟基磺酰基氨基,甲基磺酰基,甲基亚磺酰基,羧酸基或磺酸基,或 - (CH 2)n -R 1也可以是2至4个碳原子的烷基或2,3-二羟基丙基; R2是选自3-吡啶基,5-嘧啶基,2-噻吩基,2-呋喃基甲基,2-噻吩基甲基,2-咪唑基甲基,2-噻唑基甲基,3-吡啶基甲基或5-嘧啶基甲基的未取代或单取代杂环基, 其中取代基是氯,甲基,乙酰氨基,羟基,甲基亚磺酰基,甲基磺酰基,氨基羰基或氨基磺酰基; E是氢或在体外或体内容易除去的保护基; 并且当E是氢时,与无机或有机碱形成的无毒的药学上可接受的盐; 化合物及其盐可用作抗生素。